Plan B Investigation May Get No HELP In Senate
This article was originally published in The Tan Sheet
Executive Summary
FDA's handling of an emergency contraception switch may be less likely to come under investigation with new leadership on the Senate HELP committee
You may also be interested in...
FDA Comes Under Fire From Sen. Clinton Over Plan B Decision
Sen. Hillary Clinton (D-N.Y.) is calling for a hearing and separate GAO investigation into FDA's decision to deny OTC approval of Barr's Plan B (levenorgestrel) emergency contraceptive
Henney Nomination Moves To "Enzi" Game; Floor Time Is Last Hurdle
The confirmation process for FDA Commissioner-nominee Jane Henney, MD, is in the hands of the Senate leadership after the Senate Labor & Human Resources Committee voted in favor of the nomination Sept. 23.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC